Insider track record
OtherAcross 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Dar Zavain. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. In total, 22 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €167k. History available since 7 December 2021. The latest transaction was disclosed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Dar Zavain
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
88,424 sharesClass A Common StockSEC:0001601830-26-000084:0
4,902 shares0Class A Common StockSEC:0001852075-26-000004:0
3,571 shares0Class A Common StockSEC:0001852075-26-000002:0
2,941 shares0Class A Common StockSEC:0001852075-25-000005:0
2,924 shares0Class A Common StockSEC:0001601830-25-000115:0
22,016 shares0Class A Common StockSEC:0001601830-25-000109:0
2,745 shares0Class A Common StockSEC:0001601830-25-000055:0
1,907 shares0Class A Common StockSEC:0001601830-25-000006:0
2,229 shares0Class A Common StockSEC:0001601830-24-000173:0
1,843 shares0Class A Common StockSEC:0001601830-24-000098:0
13,097 shares0Class A Common StockSEC:0001601830-24-000070:0
1,467 shares0Class A Common StockSEC:0001601830-24-000029:0
1,393 shares0Class A Common StockSEC:0001601830-24-000002:0
20,141 shares@ US$9.00100.0% of flowClass A Common StockSEC:0001209191-23-059032:0
1,920 shares0Class A Common StockSEC:0001209191-23-052066:0
1,863 shares0Class A Common StockSEC:0001209191-23-041654:0
12,612 shares0Class A Common StockSEC:0001209191-23-038842:0
1,996 shares0Class A Common StockSEC:0001209191-23-026049:0
1,996 shares0Class A Common StockSEC:0001209191-23-023436:0
2,420 shares0Class A Common StockSEC:0001209191-22-041947:0
18,145 shares0Class A Common StockSEC:0001209191-22-037635:0
3,599 shares0Class A common stockSEC:0000905718-21-001585:0
About Dar Zavain
Dar Zavain is a director of Recursion Pharmaceuticals, INC.. Across 18 filings in total, the 18 sampled filings cover the period from 2021-12-09 to 2026-06-22, with EUR 0 of purchases and EUR 166514 of sales, mainly tied to an attribution.